Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)
Authors:
Open Access
- 25 April 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 20 (7) , 861-868
Abstract
The objective of the study was that the regulatory T cells (Treg) that specialize in the suppression of immune responses might be critically involved in the pathogenesis of autoimmune disease. As for systemic lupus erythematosus (SLE), however, published data concerning Treg phenotype and function are partly conflicting. We therefore performed quantitative and qualitative analyses of naturally occurring CD4+CD25+ Treg from SLE patients as compared with healthy controls (HC) in order to further elucidate the role of Treg in this systemic autoimmune disease. The phenotype of peripheral blood CD4+CD25+ Treg was determined by flow cytometry (FACS) in SLE patients and HC. Treg were isolated from SLE patients and HC and their functional capacity was analyzed in suppression assays. Phenotypic and functional data were correlated with clinical data. Decreased proportions of CD4+ Treg with high-level expression of CD25 (CD4+CD25hi) were observed in active and inactive SLE patients (0.96 ± 0.08 and 1.17 ± 0.08%, respectively) as compared with HC (2 ± 0.1%). In contrast to HC, Treg from SLE patients displayed an activated phenotype as determined by the expression of CD69, CD71 and HLA-DR. The suppressive capacity of isolated Treg from SLE patients, however, was significantly reduced as compared with HC. Proportions of CD4+CD25hi T cells and the suppressive capacity of Treg were inversely correlated with the clinical disease activity in SLE patients. Our data describe quantitative and qualitative defects of Treg in SLE patients. These deficiencies might contribute to the breakdown of self-tolerance and the development of the autoimmune response in SLE patients.Keywords
This publication has 33 references indexed in Scilit:
- Transient expression of FOXP3 in human activated nonregulatory CD4+ T cellsEuropean Journal of Immunology, 2006
- Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoidsAnnals of the Rheumatic Diseases, 2006
- IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoBlood, 2006
- Bead-isolated human CD4+CD25+ T regulatory cells are anergic and significantly suppress proliferation of CD4+CD25− T responder cellsClinical Immunology, 2006
- Human CD25high Tregs: Isolation by beads versus by FACS sortingClinical Immunology, 2006
- Transcriptional repression of interleukin-2 in human systemic lupus erythematosusAutoimmunity Reviews, 2006
- CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitisBlood, 2004
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple SclerosisJournal of Experimental Medicine, 2004
- Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritisEuropean Journal of Immunology, 2003
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992